Terns Pharmaceuticals Inc (TERN)
5.79
+0.08
(+1.40%)
USD |
NASDAQ |
Nov 22, 16:00
5.79
0.00 (0.00%)
After-Hours: 20:00
Terns Pharmaceuticals Free Cash Flow: -74.83M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -74.83M |
| June 30, 2024 | -79.09M |
| March 31, 2024 | -75.89M |
| December 31, 2023 | -67.44M |
| September 30, 2023 | -59.33M |
| June 30, 2023 | -52.05M |
| March 31, 2023 | -50.22M |
| December 31, 2022 | -49.38M |
| Date | Value |
|---|---|
| September 30, 2022 | -49.01M |
| June 30, 2022 | -43.74M |
| March 31, 2022 | -41.37M |
| December 31, 2021 | -42.17M |
| September 30, 2021 | -38.73M |
| June 30, 2021 | -36.89M |
| March 31, 2021 | -37.02M |
| December 31, 2020 | -30.39M |
Free Cash Flow Range, Past 5 Years
-79.09M
Minimum
Jun 2024
-30.39M
Maximum
Dec 2020
-51.72M
Average
-49.20M
Median
Free Cash Flow Benchmarks
| Eli Lilly and Co | -2.275B |
| Viking Therapeutics Inc | -74.25M |
| Biomarin Pharmaceutical Inc | 300.88M |
| Elite Pharmaceuticals Inc | 1.685M |
| Verrica Pharmaceuticals Inc | -59.62M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -16.46M |
| Cash from Investing (Quarterly) | 31.75M |
| Cash from Financing (Quarterly) | 163.29M |
| Free Cash Flow Per Share (Quarterly) | -0.2115 |
| Free Cash Flow Yield | -17.29% |